Corgi All World 2x Daily ETF(WX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

WX Corgi All World 2x Daily ETF

盘前交易 10-22 08:21:38 EDT

24.04

+0.24

+1.02%

最高24.04	最低24.04	成交量7.00
今开23.80	昨收23.80	日振幅0.00%
总市值60.11万	流通市值60.11万	总股本2.50万
成交额168.00	换手率0.03%	流通股本2.50万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"WX","market":"US","secType":"STK","nameCN":"Corgi All World 2x Daily ETF","latestPrice":24.0443,"timestamp":1792612800000,"preClose":23.8026,"halted":0,"volume":7,"delay":0,"changeRate":0.010154352885819113,"floatShares":25000,"shares":25000,"eps":0,"marketStatus":"盘前交易","change":0.2417,"latestTime":"10-22 08:21:38 EDT","open":23.8026,"high":24.0443,"low":24.0443,"amount":168,"amplitude":0,"askPrice":38.47,"askSize":200,"bidPrice":13.72,"bidSize":100,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792675800000},"marketStatusCode":1,"adr":0,"exchange":"CBOE","adjPreClose":24.0443,"nav":23.79,"aum":594750,"bidAskSpread":0,"volumeRatio":0.0348605438802614},"requestUrl":"/m/hq/s/WX/tweets","defaultTab":"tweets","newsList":[{"id":"2677935858","title":"港股CXO板块午后走低，昭衍新药跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677935858","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677935858?lang=zh_cn&edition=full","pubTime":"2026-10-22 13:10","pubTimestamp":1792645817,"startTime":"0","endTime":"0","summary":"10月22日，港股CXO板块午后走低，昭衍新药跌超10%，凯莱英跌近9%，药明生物、泰格医药、金斯瑞生物科技、药明康德跌超5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610223903905888.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610223903905888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["VXUS","BK1576","BK0216","06127","KCAI","CXO","603127","WX","BK4585","BK4588","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677565933","title":"港股CXO概念股午后走弱，昭衍新药跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677565933","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677565933?lang=zh_cn&edition=full","pubTime":"2026-10-22 13:03","pubTimestamp":1792645436,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CXO","KCAI","WX","VXUS","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676666032","title":"ADC出海新纪录，翰森制药冲高9%，港股通创新药大受提振！CXO、互联网医疗齐升，港股通医疗ETF华宝爆量上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2676666032","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676666032?lang=zh_cn&edition=full","pubTime":"2026-10-20 19:08","pubTimestamp":1792494480,"startTime":"0","endTime":"0","summary":"A股医疗板块低开高走，迪安诊断20CM涨停，医疗ETF华宝收复半年线；创新药延续修复，药ETF华宝四连涨。港股大市调整，医药板块走出独立行情，创新药、CXO、互联网医疗等多点开花！港股通医疗ETF华宝、港股通创新药ETF华宝标的指数盘中分别上探3%、2.4%，收涨1.58%、1.49%。超155亿美元BD大单提振，翰森制药盘中暴拉逾9%，收涨8.32%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-10-20/doc-inivwpzm6468595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK1574","FLHK","LNGR","CXO","BK1191","06978","BK1583","WX","159992","BK1589","IBBQ","512170","03692","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676655678","title":"155亿美元！翰森制药再签罗氏，股价狂飙！药明系上演“纠错行情”，高CXO含量ETF（159137）标的指数摸高3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676655678","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676655678?lang=zh_cn&edition=full","pubTime":"2026-10-20 11:03","pubTimestamp":1792465380,"startTime":"0","endTime":"0","summary":"10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。CXO同步走强，药明生物领涨超6%，药明合联涨超2%。消息面，翰森制药10月19日发布公告，已与罗氏订立战略合作及授权协议。以药明系为代表的CXO强势反弹，或受益于“错杀”修复。捕捉港股医药高弹性机遇，关注两个T+0交易工具：港股通创新药ETF华宝：标的指数100%布局创新药研发类公司，7成仓位押注创新药研发龙头。港股通医疗ETF华宝：标的指数AI制药含量超73%，CXO含量近60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-10-20/doc-inivvsvv6616806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03692","BK1191","BK1583","BK4585","FDN","CXO","159137","WX","BK1589","BK4550","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676014658","title":"嘉实基金郝淼：创新药产业链景气度或持续向上，CXO受益内外需共振","url":"https://stock-news.laohu8.com/highlight/detail?id=2676014658","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676014658?lang=zh_cn&edition=full","pubTime":"2026-10-20 10:00","pubTimestamp":1792461600,"startTime":"0","endTime":"0","summary":"10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。他预计2026全年，整个创新药产业链景气度或持续向上。中国创新药产业上游企业有望同时受益于内外需共振，仍有较大的成长空间。综合而言，郝淼预计，中国创新药产业全球化发展的新周期仍会持续，两三年后有望看到一批中国本土开发的创新药品种在全球实现商业化销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-10-20/doc-inivvsvr7584596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","MEDX","WX","159992","BK1161","BK1574","IBBQ","CXO","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676508415","title":"午后突升，医疗ETF华宝、药ETF华宝携手走强！CXO强势反弹，康龙化成冲涨8%！中药股获追捧，达仁堂涨停封板","url":"https://stock-news.laohu8.com/highlight/detail?id=2676508415","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676508415?lang=zh_cn&edition=full","pubTime":"2026-10-19 14:25","pubTimestamp":1792391100,"startTime":"0","endTime":"0","summary":"CXO龙头领涨，康龙化成涨超8%，凯莱英涨超4%；医械股同步活跃，新产业涨近6%。制药板块午后亦启动，中药股强势，达仁堂涨停封板！分析指出，本次征求意见稿较草案口径收窄，创新药授权出海不受限制，且对CXO企业经营无影响，持续看好中国创新药及产业链在全球范围内影响力提升，行业景气度维持上行。药ETF华宝及其联接基金、医疗ETF华宝的风险等级为R3-中风险，适宜平衡型及以上的投资者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-10-19/doc-inivtuen0898075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0164","03759","BK0216","BK0239","WX","BK0188","600329","BK0060","300759","BK1576","CXO","512170","BK1141","562050","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676576180","title":"华泰证券港股策略：红利继续做底仓 可阶段性重点关注创新药及CXO龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2676576180","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676576180?lang=zh_cn&edition=full","pubTime":"2026-10-19 07:54","pubTimestamp":1792367659,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","CXO","MEDX","KCAI","LNGR","BK4585","VXUS","BK4588","WX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676521071","title":"医药内部也不是一条赛道：大药企、创新药与CXO为何不能用同一套轮动逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2676521071","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676521071?lang=zh_cn&edition=full","pubTime":"2026-10-18 16:18","pubTimestamp":1792311480,"startTime":"0","endTime":"0","summary":"礼来、AbbVie等制药巨头股价走强，容易被概括为“资金从AI转向医药”。但股价接近高位，不等于资金已经系统性迁移：现有公开线索没有提供相关个股的具体涨幅区间、指数资金流、ETF申赎或全 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261018/c680806232.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261018/c680806232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["CXO","159938","WX","IBBQ","159992","BK1161","09939","MEDX","LNGR","BK1515","BK1574","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676237815","title":"AI热度与医药行情并非跷跷板：从研发投入看CXO的传导链条","url":"https://stock-news.laohu8.com/highlight/detail?id=2676237815","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676237815?lang=zh_cn&edition=full","pubTime":"2026-10-18 08:18","pubTimestamp":1792282680,"startTime":"0","endTime":"0","summary":"礼来、AbbVie等制药巨头股价走强，市场很容易把行情概括为“资金从AI转向医药”。但股价靠近高位，和资金正在系统性撤离AI，是两回事。现有公开线索没有提供相关个股的具体涨幅区间、指数资 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261018/c680804804.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261018/c680804804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["159938","CXO","CHAT","AGIX","BK1574","AIPO","WX","BK1515","ARTY","QTOC","VTHR","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675094370","title":"南方港股医药三季报解码，减权益、加CXO，资金在押注什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2675094370","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675094370?lang=zh_cn&edition=full","pubTime":"2026-10-15 13:05","pubTimestamp":1792040700,"startTime":"0","endTime":"0","summary":"一、净值与份额同步增长，权益占比下降10月13日，南方港股医药行业混合基金率先披露2026年公募基金行业首份三季报，基金经理对医药行业的最新观点随之出炉。得益于三季度港股医药板块(如恒 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261015/c680723687.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261015/c680723687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["KURE","159718","CXO","WX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675381393","title":"港股CXO概念股盘初下挫，金斯瑞生物科技跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675381393","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675381393?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:34","pubTimestamp":1791855288,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","BK4585","WX","KCAI","VXUS","CXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674892318","title":"【券商聚焦】中泰国际：多家药企将公布重要数据 推荐创新药与CXO龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2674892318","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674892318?lang=zh_cn&edition=full","pubTime":"2026-10-09 08:38","pubTimestamp":1791506310,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中泰国际表示，多家创新药企业将于10月下旬ESMO公布重要临床数据。ESMO是欧洲最具盛名和影响力的肿瘤学会议，LBA是最高级别的研究成果展示，因此ESMO公布的LBA在医药行业广受关注。中国企业入选的LBA中，有四项入选最高级别的主席研讨会。该机构认为，以上情况表明中国创新药研发能力在海外广受认可，因此创新药板块值得继续关注。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993342","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","SG9999002463.SGD","LU0348827113.USD","02269","LU0307460666.USD","LU0572944931.SGD","LU0348767384.USD","LU0561508036.HKD","LU1960683339.HKD","09926","LU1242518931.SGD","00013","LU1008478684.HKD","01177","01801","BK1521","LU1831875114.USD","LU2488822045.USD","159992","KCE","LU2399975544.HKD","01093","02359","WX","LU0067412154.USD","LU0029874905.USD","LU0708995153.HKD","LU0149534421.HKD","LU0327786744.USD","IE0008369823.USD","BK1500","LU0348783233.USD","LU2097828714.EUR","KURE","IBBQ","06978","IE00BZ08YR35.GBP","LU0320764599.SGD","06821","LU1688375341.USD","CXO","BK1191","LU2097828557.USD","LU0314109678.HKD","LU0823426308.USD","LU2125910500.SGD","06160","IE00B5MMRT66.SGD","02268","LNGR"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2673035134","title":"小摩：不太担心利率上升影响中国医疗健康行业 继续看好生物科技及CXO","url":"https://stock-news.laohu8.com/highlight/detail?id=2673035134","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673035134?lang=zh_cn&edition=full","pubTime":"2026-10-06 11:32","pubTimestamp":1791257520,"startTime":"0","endTime":"0","summary":"另外，该行预期本轮加息周期将于12月再加息一次后结束，而非延续至明年的长期紧缩，因此对利率上升影响中国医疗健康估值并不太担心，并继续看好生物科技及CXO子板块。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0034235295.USD","LU0572944931.SGD","159837","LU1670627923.USD","VHT","06990","KBWB","LU0708995153.HKD","GDOC","MEDX","TFNS","TRUF","VFH","IXJ","KURE","LU0345769128.USD","PEX","IYG","IXG","FTXO","LU0976567544.SGD","AGNG","159760","EQRR","JPO","UYG","WX","SYNB","LABU","CXO","02268","HBImain","LNGR","02359","XLF","03696","IBBJ","IE00BKDWB100.SGD","02269","FNCL","IEIH","LU0345769631.USD","01548","IYF","JPMO","XBI","XLBI","LU2168564065.EUR","LU1974910355.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672758061","title":"创新药出海之后，CXO能否接住订单复苏？","url":"https://stock-news.laohu8.com/highlight/detail?id=2672758061","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672758061?lang=zh_cn&edition=full","pubTime":"2026-10-01 16:18","pubTimestamp":1790842680,"startTime":"0","endTime":"0","summary":"9月医药板块的重估，起点是创新药出海交易的密集落地，真正决定行情能否继续的，却是一个更具体的问题：BD交易能否转化为CXO产业链的订单、收入和利润？公开资料显示，国家药监局9月14日披 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261001/c680429674.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261001/c680429674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["06978","BK1161","IBBQ","MEDX","LNGR","159992","WX","CXO","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671271309","title":"科创板收评：权重股拖累科创50指数下行 创新药械、CXO板块逆势爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2671271309","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671271309?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:04","pubTimestamp":1790751854,"startTime":"0","endTime":"0","summary":"今日，科创50指数收跌2.58%。盘面上，寒武纪、中芯国际、海光信息、澜起科技等权重股普遍下挫。分行业来看，创新药械、CXO板块逆势爆发，康希诺、泰诺麦博20cm涨停，南模生物涨超19%，近岸蛋白涨超13%，洁特生物涨超12%。半导体板块情绪低迷，芯原股份跌超11%，气派科技、杰华特跌超7%，华峰测控跌超6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11134,202609303887676434.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11134,202609303887676434.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["399265","159371","WX","CXO","KSTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671725228","title":"盈利修复叠加出海提速，创新药与CXO投资机遇受关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2671725228","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671725228?lang=zh_cn&edition=full","pubTime":"2026-09-30 07:14","pubTimestamp":1790723656,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CXO","WX","MEDX","LNGR","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670224407","title":"CXO概念活跃 华神科技涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2670224407","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670224407?lang=zh_cn&edition=full","pubTime":"2026-09-28 09:32","pubTimestamp":1790559162,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CXO","WX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669488353","title":"港股医药实力抗跌！CXO再扛旗，核心ETF（159137）逆市收红，金斯瑞创5年新高！两个问题引发关注……","url":"https://stock-news.laohu8.com/highlight/detail?id=2669488353","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669488353?lang=zh_cn&edition=full","pubTime":"2026-09-23 19:17","pubTimestamp":1790162220,"startTime":"0","endTime":"0","summary":"AI制药产业链上游CXO全天强势，百奥赛图-B领涨近5%，金斯瑞生物科技再涨3.21%创5年新高！港股通医疗ETF华宝标的指数AI制药含量近70%，盘中冲高1.4%，收涨0.1%。图：港股通创新药ETF华宝近6月走势近期港股创新药链相对强势，回顾行情结构，两个问题引发关注：其一，AI制药热度走高，为什么CXO涨势更优。港股通创新药ETF华宝：标的指数100%布局创新药研发类公司，7成仓位押注创新药研发龙头。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-23/doc-inisvivx8562452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159137","CXO","KURE","WX","159718","BK4550","BK4585","FDN","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669139506","title":"医药外包概念盘初走高 昭衍新药（06127）涨6.14% 机构指CXO为医药行业中最亮眼板块之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2669139506","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669139506?lang=zh_cn&edition=full","pubTime":"2026-09-21 10:10","pubTimestamp":1789956632,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股医药外包概念盘初走高，截至发稿，昭衍新药（06127）涨6.14%，药明生物（02269）涨4.97%，金斯瑞生物科技（01548）涨4.47%，维亚生物（01873）涨3.75%，药明康德（02359）涨3.40%，泰格医药（03347）涨2.52%，康龙化成（03759）涨2.64%。中邮证券研究指，2026中报看，CXO行业是医药行业中最亮眼板块之一。数据上看，CDMO龙头、安评及临床CRO是三条景气主线。估值上看，CDMO龙头公司按2027PE仍处于合理区间，CRO环节公司报表仍处修复阶段，新签高毛利订单待转化，因此表观估值较高，但预计随着订单的逐渐周转快速消化。","market":"sg","thumbnail":"https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992050","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320223.HKD","159938","CXO","BK1515","HK0000306701.USD","LU2242644610.SGD","LU0181495838.USD","BK1589","BK1141","03347","LU0516422952.EUR","SG9999002463.SGD","LU0516422366.SGD","BK1161","02359","01548","06127","KURE","LU0348766576.USD","WX","LU0588546209.SGD","LU0039217434.USD","03759","LU0029874905.USD","LU0516423174.USD","LU0359201612.USD","LU0516423091.SGD","LU0051755006.USD","LU1880383366.USD","LU2125910500.SGD","LU0307460666.USD","09939","LU0348825331.USD","LU1794554557.SGD","01873","LU0540923850.HKD","603127","LU3063872942.SGD","LU0359202008.SGD","LU0561508036.HKD","LU0516422440.USD","LU0029874061.USD","LU0456846285.SGD","BK1583","BK1610","02269","LU0052750758.USD","LU1242518857.USD","LU0043850808.USD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668919819","title":"CXO板块上扬 昭衍新药（06127）涨5.64%、金斯瑞生物科技（01548）涨4.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668919819","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668919819?lang=zh_cn&edition=full","pubTime":"2026-09-18 09:46","pubTimestamp":1789695974,"startTime":"0","endTime":"0","summary":"金吾财讯 | CXO板块上扬，昭衍新药 涨5.64%，金斯瑞生物科技涨4.78%，维亚生物涨2.15%，泰格医药涨1.93%，药明生物涨1.80%，凯莱英涨1.79%，药明康德涨1.01%，百济神州涨0.95%。中信建投近日研报指，CXO是创新药产业链专业化分工的重要载体，也是连接药物研发与商业化生产的关键基础设施。随着内外需改善逐步传导至订单与业绩，CXO有望进入新一轮增长阶段。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991930","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0228659784.USD","IE00B0JY6N72.USD","LU0561508036.HKD","LU0181495838.USD","LU0348735423.USD","LU3063872942.SGD","LU0348825331.USD","LU1719994722.HKD","LU0634319403.HKD","BK1521","LU1242518931.SGD","LU0348827113.USD","01548","BK0216","LU0516423174.USD","LU0029874061.USD","01873","LU0456846285.SGD","LU0856984785.SGD","BK1588","LU0588546209.SGD","02359","06160","LU1880383366.USD","BK1610","02269","LU0128522744.USD","LU2039709279.SGD","06127","CXO","LU0029874905.USD","BK1161","LU0051755006.USD","LU1242518857.USD","LU0320764243.SGD","LU1688375341.USD","LU0469268626.HKD","LU0320764599.SGD","LU0359202008.SGD","SG9999002562.SGD","LU2242644610.SGD","06821","LU0828237510.HKD","LU1251922891.USD","KURE","603127","WX","LU0039217434.USD","LU0052750758.USD","03347"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxiapptec.com","stockEarnings":[{"period":"1week","weight":0.0107},{"period":"1month","weight":-0.0382},{"period":"3month","weight":0.0361},{"period":"6month","weight":-0.0273},{"period":"ytd","weight":-0.0273}],"compareEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":-0.0005},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.0829},{"period":"1year","weight":0.1516},{"period":"ytd","weight":0.1337}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"药明康德在开曼群岛注册成立于2004年6月3日，没有显著的资产或它自己的业务。几乎所有在中国开展的业务都是通过其主要运营子公司，WXAT，一家于2000年12月成立的药明康德新药开发有限公司。公司的核心业务是提供发现化学服务在药物发现过程的开始合成的小分子。该公司是一家全球领先的制药、生物技术以及医疗器械研发外包服务公司。公司的核心业务是在药物发展过程的开始阶段为合成小分子提供发现化学服务。公司主要在中国和美国经营业务。公司在研发过程中提供一系列全方位的实验室及制造服务给客户，这些客户包括许多世界一流的制药、生物技术和医疗器械公司。公司的服务旨在帮助全球客户缩短时间，并通过提供具有成本效益和高效率的外包解决方案，降低药品和医疗器械的研发成本。","exchange":"CBOE","name":"Corgi All World 2x Daily ETF","nameEN":"Corgi All World 2x Daily ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corgi All World 2x Daily ETF(WX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Corgi All World 2x Daily ETF(WX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Corgi All World 2x Daily ETF,WX,Corgi All World 2x Daily ETF股票,Corgi All World 2x Daily ETF股票老虎,Corgi All World 2x Daily ETF股票老虎国际,Corgi All World 2x Daily ETF行情,Corgi All World 2x Daily ETF股票行情,Corgi All World 2x Daily ETF股价,Corgi All World 2x Daily ETF股市,Corgi All World 2x Daily ETF股票价格,Corgi All World 2x Daily ETF股票交易,Corgi All World 2x Daily ETF股票购买,Corgi All World 2x Daily ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corgi All World 2x Daily ETF(WX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Corgi All World 2x Daily ETF(WX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}